Influenza infection
Resumen
Definición
Anamnesis y examen
Principales factores de diagnóstico
- winter season
- current influenza outbreak
- unvaccinated
- fever with cough
Otros factores de diagnóstico
- sore throat
- cervical lymphadenopathy
- dyspnea
Factores de riesgo
- age ≥65 years
- age 6-59 months
- chronic cardiovascular or respiratory conditions
- diabetes
- hemoglobinopathy
- immunocompromised status
- chronic kidney disease (CKD)
- pregnancy
- caregivers and household contacts of high-risk groups
- healthcare workers
Pruebas diagnósticas
Primeras pruebas diagnósticas para solicitar
- clinical diagnosis
Tests to avoid
- broad respiratory pathogen panels
- serology
Pruebas diagnósticas que deben considerarse
- molecular assays
- antigen detection tests
- viral culture
- chest x-ray
Algoritmo de tratamiento
exposure to infected individual(s) in at-risk population
adults
children
Colaboradores
Autores
Kyle Eggleton, MBChB PhD FRNZCGP(Dist)
Associate Dean Rural
Department of General Practice and Primary Health Care
University of Auckland
Auckland
New Zealand
Divulgaciones
KE declares that he has no competing interests.
Rachel Roskvist, MBChB, FRNZCGP, MHSc
Senior Lecturer
Department of General Practice and Primary Health Care
University of Auckland
Auckland
New Zealand
Divulgaciones
RR declares that she has no competing interests.
Bruce Arroll, MBChB PhD FRNZCGP
Department of General Practice and Primary Health Care
University of Auckland
Auckland
New Zealand
Divulgaciones
BA declares that he has no competing interests.
Agradecimientos
Dr Kyle Eggleton, Dr Rachel Roskvist, and Professor Bruce Arroll would like to gratefully acknowledge Dr Cristine Radojicic, a previous contributor to this topic.
Divulgaciones
CR declares that she is on Advisory boards for CSL Behring and Speakers Bureau Biocryst.
Revisores por pares
Michael Ison, MD
Chief
Respiratory Diseases Branch
National Institute of Allergy and Infectious Diseases
Bethesda
MD
Divulgaciones
MI declares that he has no competing interests.
Waleed Javaid, MD, FACP, FIDSA
Associate Professor
Medical Director of Infection Control
Infectious Disease
Department of Medicine
SUNY Upstate Medical University
Syracuse
NY
Divulgaciones
WJ declares that he has no competing interests.
Rachel L. Miller, MD, FAAAAI
Associate Professor of Clinical Medicine and Environmental Health Sciences
Columbia University College of Physicians and Surgeons
New York
NY
Divulgaciones
RLM declares that she has no competing interests.
Mark Sands, MD, FAAAAI
Chief
SUNY Buffalo School of Medicine
Division Allergy and Immunology
Buffalo
NY
Divulgaciones
MS declares that he has no competing interests.
An De Sutter, MD, PhD
Associate Professor
Department of General Practice and Primary Health Care
Ghent University
Ghent
Belgium
Divulgaciones
ADS declares that she has no competing interests.
Agradecimiento de los revisores por pares
Los temas de BMJ Best Practice se actualizan de forma continua de acuerdo con los desarrollos en la evidencia y en las guías. Los revisores por pares listados aquí han revisado el contenido al menos una vez durante la historia del tema.
Divulgaciones
Las afiliaciones y divulgaciones de los revisores por pares se refieren al momento de la revisión.
Referencias
Artículos principales
Uyeki TM, Bernstein HH, Bradley JS, et al. Clinical practice guidelines by the Infectious Diseases Society of America: 2018 update on diagnosis, treatment, chemoprophylaxis, and institutional outbreak management of seasonal influenza. Clin Infect Dis. 2019 Mar 5;68(6):e1-47.Texto completo Resumen
Centers for Disease Control and Prevention. Influenza (flu). Feb 2024 [internet publication].Texto completo
Centers for Disease Control and Prevention. Prevention and control of seasonal influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices - United States, 2024-25 Influenza Season. Aug 2024 [internet publication].Texto completo Resumen
Centers for Disease Control and Prevention. Child and adolescent immunization schedule by age (addendum updated July 2, 2025): recommendations for ages 18 years or younger, United States, 2025. Jul 2025 [internet publication].Texto completo
Centers for Disease Control and Prevention. Adult immunization schedule by age (addendum updated July 2, 2025): recommendations for ages 19 years or older, United States, 2025. Jul 2025 [internet publication].Texto completo
Centers for Disease Control and Prevention. Influenza antiviral medications: summary for clinicians. Dec 2023 [internet publication].Texto completo
Artículos de referencia
Una lista completa de las fuentes a las que se hace referencia en este tema está disponible para los usuarios con acceso a todo BMJ Best Practice.
Diferenciales
- Coronavirus disease 2019 (COVID-19)
- Bacterial pneumonia
- Rhinovirus infection
Más DiferencialesGuías de práctica clínica
- Statement on seasonal influenza vaccines for 2025-2026
- Child and adolescent immunization schedule by age: recommendations for ages 18 years of younger, United States, 2025
Más Guías de práctica clínicaFolletos para el paciente
Flu
Antibiotics: what you need to know
Más Folletos para el paciente
Inicie sesión o suscríbase para acceder a todo el BMJ Best Practice
El uso de este contenido está sujeto a nuestra cláusula de exención de responsabilidad